None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) A person who has consented to participate in this study and signed a written consent form. 2) Adults aged 30 to under 60 years old. 3) Those who have dry skin (Cornometer®CM825 measured moisture content index of 49 or less), have begun to produce wrinkles around their eyes, or have already produced them (visual evaluation grade 3 or more)
Exclusion criteria
Exclusion criteria: Those who meet the conditions described below are excluded. 1) Those who have abnormal skin conditions such as moles, acne, erythema, and capillaries. 2) Those who are currently suffering from or undergoing treatment for skin diseases such as atopic dermatitis and psoriasis. 3) Those who take oral contraceptives, hormones, diuretics, and immune drugs. 4) Users of oral medications containing steroids or retinoids and skin external applications containing the ingredients within 3 months of their first visit. 5) Users of functional cosmetics (retinoid agent, retinol, AHA) or high-humidification cosmetics to improve wrinkles within 2 weeks of their first visit. 6) A person who have undergone skin exfoliation, laser, chemical peeling, and other skin care procedures on the face within one month of his first visit, or Botox and filler procedures on the face within six months. 7) Patients with diseases such as uncontrolled hypertension, uncontrolled diabetes mellitus, renal dysfunction, and liver dysfunction. 8) Those who continue to eat health functional foods within a month of their first visit. 9) Smokers or those who have smoked for less than 1 year. 10) Participants in other clinical studies within 1 month of their first visit (within 6 months for clinical studies related to skin health) 11) Pregnant or lactating women, those who plan to become pregnant. 12) Those who have hypersensitivity to test/control food or its ingredients, or have experienced severe food allergy reactions. 13) Those who are judged inappropriate by the researcher to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Skin moisture, percutaneous moisture loss, dead skin cell, skin elasticity, skin texture, wrinkles around the eyes, skin luster, moisture in the skin, overall improvement | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical pathology test(blood, urine);Vital signs;Adverse event | — |
Countries
Korea, Republic of
Contacts
Yonsei University Health System, Severance Hospital